Roohi Peter, Labiotech reporter covering neuroscience and gene therapy. Willow Shah-Neville, Labiotech reporter tracking clinical-stage biotech and cardio/metabolic trials. Jules Adam, Labiotech reporter known for oncology and immunology analysis. They spotlight 15 biopharma companies to watch in 2026. Topics include gene and cell therapies, radiopharma and isotopes, microbiome commercialisation, GLP-1 rivalry, base editing, psychedelics trials, and novel neuroscience drugs.
